nevirapine has been researched along with Peripheral Nerve Diseases in 11 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nevirapine induced rash and SJ syndrome developed within first month of treatment followed by anemia, hepatitis and gastritis which developed within 6 months after initiation of ART." | 3.77 | HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India. ( Anwikar, SR; Bandekar, MS; Kshirsagar, NA; Pazare, AP; Smrati, B; Tatke, PA, 2011) |
| " Pressure of work and insufficient perceived benefit of side-effect recording are suspected causes." | 1.37 | Underreporting of side effects of standard first-line ART in the routine setting in Blantyre, Malawi. ( Lungu, M; Mathews, T; Tapsfield, J; van Oosterhout, JJ, 2011) |
| "To determine the incidence of clinically significant adverse events after long-term, fixed-dose, generic highly active antiretroviral therapy (HAART) use among HIV-infected individuals in South India, we examined the experiences of 3154 HIV-infected individuals who received a minimum of 3 months of generic HAART between February 1996 and December 2006 at a tertiary HIV care referral center in South India." | 1.35 | Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. ( Balakrishnan, P; Cecelia, AJ; Devaleenal, B; Flanigan, TP; Kumarasamy, N; Lai, AR; Mayer, KH; Poongulali, S; Saghayam, S; Solomon, S; Venkatesh, KK; Yepthomi, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bokore, A | 1 |
| Korme, B | 1 |
| Bayisa, G | 1 |
| Tapsfield, J | 1 |
| Mathews, T | 1 |
| Lungu, M | 1 |
| van Oosterhout, JJ | 1 |
| Birbal, S | 1 |
| Dheda, M | 1 |
| Ojewole, E | 1 |
| Oosthuizen, F | 1 |
| van Griensven, J | 1 |
| Zachariah, R | 1 |
| Rasschaert, F | 1 |
| Mugabo, J | 1 |
| Atté, EF | 1 |
| Reid, T | 1 |
| Anwikar, SR | 1 |
| Bandekar, MS | 1 |
| Smrati, B | 1 |
| Pazare, AP | 1 |
| Tatke, PA | 1 |
| Kshirsagar, NA | 1 |
| Phanuphak, N | 1 |
| Ananworanich, J | 1 |
| Teeratakulpisarn, N | 1 |
| Jadwattanakul, T | 1 |
| Kerr, SJ | 1 |
| Chomchey, N | 1 |
| Hongchookiat, P | 1 |
| Mathajittiphun, P | 1 |
| Pinyakorn, S | 1 |
| Rungrojrat, P | 1 |
| Praihirunyakit, P | 1 |
| Gerschenson, M | 1 |
| Phanuphak, P | 1 |
| Valcour, V | 1 |
| Kim, JH | 1 |
| Shikuma, C | 1 |
| Jamisse, L | 1 |
| Balkus, J | 1 |
| Hitti, J | 1 |
| Gloyd, S | 1 |
| Manuel, R | 1 |
| Osman, N | 1 |
| Djedje, M | 1 |
| Farquhar, C | 1 |
| Forna, F | 1 |
| Liechty, CA | 1 |
| Solberg, P | 1 |
| Asiimwe, F | 1 |
| Were, W | 1 |
| Mermin, J | 1 |
| Behumbiize, P | 1 |
| Tong, T | 1 |
| Brooks, JT | 1 |
| Weidle, PJ | 1 |
| Laurent, C | 1 |
| Bourgeois, A | 1 |
| Mpoudi-Ngolé, E | 1 |
| Ciaffi, L | 1 |
| Kouanfack, C | 1 |
| Mougnutou, R | 1 |
| Nkoué, N | 1 |
| Calmy, A | 1 |
| Koulla-Shiro, S | 1 |
| Delaporte, E | 1 |
| Kumarasamy, N | 1 |
| Venkatesh, KK | 1 |
| Cecelia, AJ | 1 |
| Devaleenal, B | 1 |
| Lai, AR | 1 |
| Saghayam, S | 1 |
| Balakrishnan, P | 1 |
| Yepthomi, T | 1 |
| Poongulali, S | 1 |
| Flanigan, TP | 1 |
| Solomon, S | 1 |
| Mayer, KH | 1 |
| Markus, R | 1 |
| Brew, BJ | 1 |
3 trials available for nevirapine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Diet; Drug Administrati | 2012 |
Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens.
Topics: Adult; Alanine Transaminase; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asparta | 2007 |
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combin | 2008 |
8 other studies available for nevirapine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Cros | 2018 |
Underreporting of side effects of standard first-line ART in the routine setting in Blantyre, Malawi.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Ambulatory Care Facilities; Anti-HIV Agents; Cross-S | 2011 |
Adverse drug reactions associated with antiretroviral therapy in South Africa.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Fema | 2016 |
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
Topics: Acidosis, Lactic; Adult; Age Factors; Anti-HIV Agents; Drug Therapy, Combination; Drugs, Generic; Ex | 2010 |
HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.
Topics: Alkynes; Anemia; Antiretroviral Therapy, Highly Active; Benzoxazines; Chemical and Drug Induced Live | 2011 |
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, H | 2007 |
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Chemica | 2008 |
HIV-1 peripheral neuropathy and combination antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; | 1998 |